Celexa and Adempas drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Celexa (citalopram hydrobromide) and Adempas (riociguat). Common drug interactions include chronic obstructive pulmonary disease among females and pulmonary thrombosis among males.

The phase IV clinical study analyzes what interactions people have when they take Celexa and Adempas. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Celexa?

Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,390 Celexa users. Check the latest studies of Celexa.

What is Adempas?

Adempas has active ingredients of riociguat. eHealthMe is studying from 29,741 Adempas users. Check the latest studies of Adempas.



On Jul, 17, 2026

45 people who take Celexa and Adempas together, and have interactions are studied.

Celexa and Adempas drug interactions.

What are the common drug interactions of Celexa and Adempas, by gender? *:

female:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. Nausea (feeling of having an urge to vomit)
  3. Weight increased
  4. Pulmonary hypertension (increase in blood pressure in the lung artery)
  5. Diarrhoea
  6. Hypoxia (low oxygen in tissues)
  7. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  8. Oxygen saturation decreased
  9. Pneumonia
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

male:

  1. Pulmonary thrombosis (scarring in the lungs)
  2. Chills (felling of cold)
  3. Arthralgia (joint pain)
  4. Aspartate aminotransferase increased
  5. Asthenia (weakness)
  6. Blood alkaline phosphatase decreased
  7. Blood chloride decreased
  8. Blood ethanol increased
  9. Blood potassium decreased
  10. Breath sounds

What are the common drug interactions of Celexa and Adempas, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cough
  2. Dyspnoea (difficult or laboured respiration)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Headache (pain in head)
  5. Nausea (feeling of having an urge to vomit)
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Coma (state of unconsciousness lasting more than six hours)
  8. Dizziness
  9. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

50-59:

  1. Emotional disorder
  2. Feeling cold
  3. Flushing (the warm, red condition of human skin)
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Lethargy (tiredness)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Myalgia (muscle pain)
  10. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fluid retention (an abnormal accumulation of fluid in the blood)
  3. Diarrhoea
  4. Oxygen consumption increased
  5. Abdominal pain
  6. Asthenia (weakness)
  7. Back pain
  8. Breath sounds
  9. Eye pain
  10. Eye swelling

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 34 people, 75.56%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 12 people, 26.67%

* Approximation only. Some reports may have incomplete information.

Do you take Celexa and Adempas?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Celexa and Adempas:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Celexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Adempas:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Celexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adempas and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide and riociguat (the active ingredients of Celexa and Adempas, respectively), and Celexa and Adempas (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: